Stryker Corp (SYK)
368.98
-0.61 (-0.17%)
NYSE · Last Trade: Oct 31st, 3:23 AM EDT
Medical technology company Stryker (NYSE:SYK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.2% year on year to $6.06 billion. Its non-GAAP profit of $3.19 per share was 1.9% above analysts’ consensus estimates. 
Via StockStory · October 30, 2025
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
Via Chartmill · October 30, 2025
Stryker's Q3 2025 results were mixed: EPS beat estimates but revenue slightly missed. Shares fell as the market digested the strong earnings against the updated full-year guidance.
Via Chartmill · October 30, 2025
Fenimore Sells Off All 244K WAT Shares Valued At $85.1 Million
Via The Motley Fool · October 30, 2025
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
Via Benzinga · October 30, 2025
Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday afternoon. Here’s what investors should know. 
Via StockStory · October 28, 2025
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. 
With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players. 
Via StockStory · October 24, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · October 22, 2025
Intuitive Surgical (NASDAQ: ISRG), the global leader in robotic-assisted surgery, announced a robust third quarter for 2025, sending its stock soaring as investors cheered impressive financial results and strong adoption of its latest da Vinci 5 surgical system. The company's report, released on October 21, 2025, showcased significant revenue and
Via MarketMinute · October 22, 2025
The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal.
Via MarketBeat · October 22, 2025
Via Benzinga · October 15, 2025
Via Benzinga · October 13, 2025
The surgical robotics pioneer could cement its leading position for years to come.
Via The Motley Fool · October 7, 2025
Via Benzinga · October 3, 2025
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's resilience. Despite prevailing anxieties, including a looming U.S. government shutdown and a disappointing jobs report, healthcare equities
Via MarketMinute · October 2, 2025
New York, NY – October 1, 2025 – In a surprising turn of events on Wall Street today, the healthcare sector emerged as the undisputed leader, shrugging off the dual anxieties of a U.S. government shutdown and a disappointing jobs report. As investors sought refuge in defensive plays and reacted to
Via MarketMinute · October 1, 2025
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · October 1, 2025
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign suppliers for critical health products.
Via Benzinga · September 25, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments. 
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory · September 22, 2025
Via Benzinga · September 19, 2025